| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |